Read the January 2020 Press Release from Texas A&M University that discusses monosodium luminol (GVT) and its ability to improve cognitive and mood function in Gulf War Illness.

Gulf War Illness (GWI) is a chronic multi-symptom health problem with high unmet need that affects over 250,000 people every day. GWI involves brain dysfunction, typified by memory and mood dysfunction, depression and anxiety. One of the most horrifying aspects of GWI is that it often progresses to full-blown ALS (Lou Gehrig's Disease). Click here for more information on ALS.

GWI enters the body through the nose, the mouth and the skin and is caused by multiple chemical exposures. It is exposure of this kind that causes oxidative stress and mitochondrial impairment.

There are many different ways that those who suffer from GWI could have been exposed to such chemicals:

- Anti nerve gas "vaccine"
- Clothing saturated with DEET
- Tents treated with Permethrin
- Pollution from burning oil fields

GWI & GVT

The Department of Defense (DOD) and the Veterans Administration, in partnership with BACH, evaluated GWI rats after receiving GVT for symptoms of GWI. The completed DOD study shows that GVT synergistically and dramatically protects neurons from dying, even under aggressive environments. Furthermore, the studies statistically demonstrated remission in symptoms of GWI in animals treated with GVT. Our current funding plan will raise the necessary funds to complete more testing and studies for the eventual approval and release of GVT for the treatment of GWI.